Kamran Alam, Chief Financial Officer at Taysha Gene Therapies, Inc. (TSHA), sold 63,293 shares at $17.35 ($1.1M) on 2021-08-18, disclosed to the SEC on 2021-08-20.
Open-market sale of $1.1M TSHA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.35 | 11,193 | $194K | 18.2% |
| 2 | $17.35 | 11,193 | $194K | 18.2% |
| 3 | $16.43 | 9,354 | $154K | 14.4% |
| 4 | $16.43 | 9,354 | $154K | 14.4% |
| 5 | $17.11 | 613 | $10K | 1.0% |
| 6 | $16.70 | 9,746 |
| $163K |
| 15.2% |
| 7 | $16.70 | 9,746 | $163K | 15.2% |
| 8 | $17.14 | 2,094 | $36K | 3.4% |
| Total | $16.87 avg | 63,293 | $1.1M | 100% |
| Filing → |
| TSHA | SELL | 2025-08-22 | $311K | — | Filing → |
| TSHA | SELL | 2023-08-25 | $77K | — | Filing → |
| TSHA | SELL | 2022-08-24 | $12K | — | Filing → |